Thread by @T_Fiolet

Voici un site qui regroupe une FAQ de questions courantes qui reviennent sur notre méta-analyse sur l'hydroxychloroquine et nous avons décidé d'y répondre

➡️ metahcq.wordpress.com

Notre publication : doi.org/10.1016/j.cmi.…

#metaHCQ à partager

Le sommaire des articles sur la méta-analyse et sur des questions plus générales d'épidémiologie/recherche clinique

Récemment l'American College of Cardiology écrivait sur notre article : "This meta-analysis summarizes the latest findings from studies examining the impact of HCQ

and AZI on mortality in patients with COVID-19. Findings are consistent with the prior studies showing no positive impact of HCQ treatment in COVID-19. This meta-analysis delves into subgroup analyses and explores potential sources of heterogeneity,

only to circle back to the same conclusions: HCQ is not beneficial in patients with COVID-19, and combination of HCQ and AZI is associated with an increased risk of death

There are limitations, as always, but none to justify continued use or testing of HCQ as a treatment in this patient population. It is time to put this story to rest

Source : acc.org/latest-in-card…